-
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …
You May Also Like
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Why Is There a Renewed Interest in Hemp by Textile and Manufacturing Companies?
Generation Hemp Reports Quarterly Financial Statements to SEC, Announces New Processing Contracts and Brand Launches
-
Digital Transformation Of Emerging Markets Could Mean Continued Opportunity For Newly NASDAQ Listed Japanese Company
Previously published on Benzinga HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions provider and leading development company in the enterprise business sector. In February, the company was uplisted to the Nasdaq Stock Exchange and rang the opening bell. Last June, Founder and CEO Sumitaka Kanno was honored with the Top 100 Tech Innovators & Influencers Award at InterCon Las Vegas for his significant and tangible contributions to the world of technology. HeartCore already held the largest market share in Japan for six straight years. It All Started With A Vision Founded in 2009, HeartCore (formerly XyXon Inc.) entered the market with its cornerstone HeartCore CMS rich content management…
-
MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body. Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery. Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…
-
CXM Software Creator Just Uplisted Last Month — Here’s What You May Want To Know
Previously Published on Benzinga HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions company that says it believes in making its customers and employees happy. The focus of many of its products is based on knowing the customer. When listing the three steps for successful digital marketing, HeartCore states that it emphasizes the need to know your customers, support them and keep them engaged. Who Is HeartCore Enterprises, Anyway? Headquartered in Tokyo, Japan, with offices in San Francisco, HeartCore Enterprises is a software development company in the enterprise business sector. The company booked $11 million in revenue for the 12 months ending on Sept. 30. On Feb. 9, it announced a $15 million…
-
Oil-free Air In, Oil-free Air Out: Solving Problems in Compression and the Environment
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The Carnot® Compressor compresses air with water. This company is on a mission to revolutionize the compressor industry — doing away with oil, multiple moving parts and damage to components caused by the heat of compression. This patented process has the potential to significantly reduce energy use and total cost of ownership for compressors. Air is compressed isothermally, and the heat is absorbed during the compression process. Rapid isothermal compression has long been thought unachievable. The compressed air industry is ripe for new technologies. As the industry seeks…
